JPH04124140A - Angiotensin-transforming enzyme inhibitor - Google Patents
Angiotensin-transforming enzyme inhibitorInfo
- Publication number
- JPH04124140A JPH04124140A JP2245371A JP24537190A JPH04124140A JP H04124140 A JPH04124140 A JP H04124140A JP 2245371 A JP2245371 A JP 2245371A JP 24537190 A JP24537190 A JP 24537190A JP H04124140 A JPH04124140 A JP H04124140A
- Authority
- JP
- Japan
- Prior art keywords
- enzyme inhibitor
- food
- water
- extract
- kyoho
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000002532 enzyme inhibitor Substances 0.000 title claims abstract description 8
- 229940125532 enzyme inhibitor Drugs 0.000 title claims abstract description 8
- 235000013305 food Nutrition 0.000 claims abstract description 30
- 239000004094 surface-active agent Substances 0.000 claims abstract description 13
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 13
- 239000003960 organic solvent Substances 0.000 claims abstract description 11
- 235000005979 Citrus limon Nutrition 0.000 claims abstract description 10
- 244000131522 Citrus pyriformis Species 0.000 claims abstract description 10
- 244000294611 Punica granatum Species 0.000 claims abstract description 9
- 235000014360 Punica granatum Nutrition 0.000 claims abstract description 9
- 244000099147 Ananas comosus Species 0.000 claims abstract description 7
- 235000007119 Ananas comosus Nutrition 0.000 claims abstract description 7
- 244000298697 Actinidia deliciosa Species 0.000 claims abstract description 5
- 235000009436 Actinidia deliciosa Nutrition 0.000 claims abstract description 5
- 240000000560 Citrus x paradisi Species 0.000 claims abstract description 5
- 235000007688 Lycopersicon esculentum Nutrition 0.000 claims abstract description 5
- 244000168667 Pholiota nameko Species 0.000 claims abstract description 5
- 235000014528 Pholiota nameko Nutrition 0.000 claims abstract description 5
- 240000003768 Solanum lycopersicum Species 0.000 claims abstract description 5
- 244000223760 Cinnamomum zeylanicum Species 0.000 claims abstract description 4
- 235000017803 cinnamon Nutrition 0.000 claims abstract description 4
- 150000001298 alcohols Chemical class 0.000 claims abstract description 3
- 150000002576 ketones Chemical class 0.000 claims abstract description 3
- 150000002148 esters Chemical class 0.000 claims abstract 2
- 150000002170 ethers Chemical class 0.000 claims abstract 2
- 235000017788 Cydonia oblonga Nutrition 0.000 claims description 7
- 239000005541 ACE inhibitor Substances 0.000 claims description 5
- 229940044094 angiotensin-converting-enzyme inhibitor Drugs 0.000 claims description 5
- 239000000203 mixture Substances 0.000 claims description 5
- 235000021018 plums Nutrition 0.000 claims description 5
- 241000951471 Citrus junos Species 0.000 claims description 4
- 235000001674 Agaricus brunnescens Nutrition 0.000 claims description 3
- 239000004480 active ingredient Substances 0.000 claims description 3
- 235000008331 Pinus X rigitaeda Nutrition 0.000 claims description 2
- 235000011613 Pinus brutia Nutrition 0.000 claims description 2
- 241000018646 Pinus brutia Species 0.000 claims description 2
- 239000003945 anionic surfactant Substances 0.000 claims description 2
- 239000003093 cationic surfactant Substances 0.000 claims description 2
- 101710129690 Angiotensin-converting enzyme inhibitor Proteins 0.000 claims 2
- 101710086378 Bradykinin-potentiating and C-type natriuretic peptides Proteins 0.000 claims 2
- 239000013543 active substance Substances 0.000 claims 2
- 239000000284 extract Substances 0.000 abstract description 14
- 238000000605 extraction Methods 0.000 abstract description 12
- 206010020772 Hypertension Diseases 0.000 abstract description 3
- 235000013399 edible fruits Nutrition 0.000 abstract description 3
- 239000007788 liquid Substances 0.000 abstract description 3
- 238000000926 separation method Methods 0.000 abstract description 3
- 239000007787 solid Substances 0.000 abstract description 3
- 239000002994 raw material Substances 0.000 abstract description 2
- 239000002904 solvent Substances 0.000 abstract description 2
- 235000009754 Vitis X bourquina Nutrition 0.000 abstract 3
- 235000012333 Vitis X labruscana Nutrition 0.000 abstract 3
- 240000006365 Vitis vinifera Species 0.000 abstract 3
- 235000014787 Vitis vinifera Nutrition 0.000 abstract 3
- 241000894007 species Species 0.000 abstract 3
- 235000005078 Chaenomeles speciosa Nutrition 0.000 abstract 2
- 240000004307 Citrus medica Species 0.000 abstract 2
- 240000005049 Prunus salicina Species 0.000 abstract 2
- 244000251905 Pseudocydonia sinensis Species 0.000 abstract 2
- 235000017831 Pseudocydonia sinensis Nutrition 0.000 abstract 2
- 244000111306 Torreya nucifera Species 0.000 abstract 2
- 235000006732 Torreya nucifera Nutrition 0.000 abstract 2
- 235000009018 li Nutrition 0.000 abstract 2
- 244000111489 Gardenia augusta Species 0.000 abstract 1
- 230000003213 activating effect Effects 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
- 102100030988 Angiotensin-converting enzyme Human genes 0.000 description 11
- 230000002401 inhibitory effect Effects 0.000 description 10
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 9
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 9
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 8
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Natural products CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 8
- 239000000126 substance Substances 0.000 description 8
- 230000005764 inhibitory process Effects 0.000 description 7
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 6
- 102000004190 Enzymes Human genes 0.000 description 5
- 108090000790 Enzymes Proteins 0.000 description 5
- 239000000306 component Substances 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 239000007858 starting material Substances 0.000 description 5
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- -1 taurocholic acid sodium salts Chemical class 0.000 description 4
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- 208000007530 Essential hypertension Diseases 0.000 description 3
- 201000004239 Secondary hypertension Diseases 0.000 description 3
- 230000036772 blood pressure Effects 0.000 description 3
- 229930014626 natural product Natural products 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 3
- 206010057615 Endocrine hypertension Diseases 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 244000068988 Glycine max Species 0.000 description 2
- 235000010469 Glycine max Nutrition 0.000 description 2
- 240000001462 Pleurotus ostreatus Species 0.000 description 2
- 235000001603 Pleurotus ostreatus Nutrition 0.000 description 2
- WBWWGRHZICKQGZ-UHFFFAOYSA-N Taurocholic acid Natural products OC1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(=O)NCCS(O)(=O)=O)C)C1(C)C(O)C2 WBWWGRHZICKQGZ-UHFFFAOYSA-N 0.000 description 2
- 239000006286 aqueous extract Substances 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 235000012041 food component Nutrition 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 239000003112 inhibitor Substances 0.000 description 2
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 2
- FDPIMTJIUBPUKL-UHFFFAOYSA-N pentan-3-one Chemical compound CCC(=O)CC FDPIMTJIUBPUKL-UHFFFAOYSA-N 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 206010038464 renal hypertension Diseases 0.000 description 2
- 239000012488 sample solution Substances 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 108010064733 Angiotensins Proteins 0.000 description 1
- 102000015427 Angiotensins Human genes 0.000 description 1
- 108010016626 Dipeptides Proteins 0.000 description 1
- 240000008620 Fagopyrum esculentum Species 0.000 description 1
- 235000009419 Fagopyrum esculentum Nutrition 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 241000219094 Vitaceae Species 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- KXKVLQRXCPHEJC-UHFFFAOYSA-N acetic acid trimethyl ester Natural products COC(C)=O KXKVLQRXCPHEJC-UHFFFAOYSA-N 0.000 description 1
- 239000002220 antihypertensive agent Substances 0.000 description 1
- 229940030600 antihypertensive agent Drugs 0.000 description 1
- 235000021028 berry Nutrition 0.000 description 1
- 230000004531 blood pressure lowering effect Effects 0.000 description 1
- 150000008280 chlorinated hydrocarbons Chemical class 0.000 description 1
- 239000002026 chloroform extract Substances 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- POLCUAVZOMRGSN-UHFFFAOYSA-N dipropyl ether Chemical compound CCCOCCC POLCUAVZOMRGSN-UHFFFAOYSA-N 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 235000011869 dried fruits Nutrition 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000003028 enzyme activity measurement method Methods 0.000 description 1
- 239000005428 food component Substances 0.000 description 1
- 239000005417 food ingredient Substances 0.000 description 1
- 235000021021 grapes Nutrition 0.000 description 1
- 235000009569 green tea Nutrition 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 230000001965 increasing effect Effects 0.000 description 1
- 229940126601 medicinal product Drugs 0.000 description 1
- 235000012149 noodles Nutrition 0.000 description 1
- 235000014571 nuts Nutrition 0.000 description 1
- ZWLUXSQADUDCSB-UHFFFAOYSA-N phthalaldehyde Chemical compound O=CC1=CC=CC=C1C=O ZWLUXSQADUDCSB-UHFFFAOYSA-N 0.000 description 1
- 235000013324 preserved food Nutrition 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 150000003147 proline derivatives Chemical class 0.000 description 1
- 150000003242 quaternary ammonium salts Chemical class 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000000523 sample Substances 0.000 description 1
- 238000013517 stratification Methods 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- WBWWGRHZICKQGZ-GIHLXUJPSA-N taurocholic acid Chemical compound C([C@@H]1C[C@H]2O)[C@@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@@H]([C@@H](CCC(=O)NCCS(O)(=O)=O)C)[C@@]2(C)[C@H](O)C1 WBWWGRHZICKQGZ-GIHLXUJPSA-N 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
Description
【発明の詳細な説明】
(産業上の利用分野)
本発明は、アンジオテンシン変換酵素阻害剤に関し、特
に、高血圧症の治療に有効な物質に関する。DETAILED DESCRIPTION OF THE INVENTION (Field of Industrial Application) The present invention relates to angiotensin-converting enzyme inhibitors, and particularly to substances effective in treating hypertension.
(従来の技術)
高血圧症には、本態性高血圧症と二次性高血圧症とがあ
り、アンジオテンシン変換酵素(以下、A[Bど略す)
は、本態性高血圧症及び二次性高血圧症である腎性高血
圧症或し)は内分泌性高血圧症などの疾病に大きな関わ
りを持っている。八CEは、TンジオテンシンIに作用
し、そのカルボキシル基側のジペブチM (ll+5
−Leu)を遊離し、血圧上昇活性を有するアンジオテ
ンシン■を産生ずる。従って、この酵素を阻害すれば、
血圧上昇の抑制が可能である。現実にこの観点から阻害
物質の検索が行われており、医薬品として、種々のプロ
リン誘導体が開発され、実用化されている。ただし、そ
れらは、合成物であるた於、医薬品以外では、社会に受
は入れられず、健康食品などの一般消費者向けには市場
性が乏しい。天然物では、緑茶、大豆、蕎麦デーどの阻
害能が報告されている。しかしこれら天然物のA CE
阻害能は合成物に比べ弱し)。(Prior art) Hypertension includes essential hypertension and secondary hypertension.
Essential hypertension and secondary hypertension (renal hypertension) are closely related to diseases such as endocrine hypertension. 8CE acts on T-tongiotensin I, and dipebutyM (ll+5
-Leu) and produce angiotensin (2), which has blood pressure increasing activity. Therefore, if we inhibit this enzyme,
It is possible to suppress increases in blood pressure. Searches for inhibitors have actually been conducted from this perspective, and various proline derivatives have been developed and put into practical use as pharmaceuticals. However, since they are synthetic products, they are not accepted by society as non-medicinal products, and have poor marketability for general consumers such as health foods. Among natural products, the inhibitory ability of green tea, soybeans, and soba noodles has been reported. However, the ACE of these natural products
The inhibitory ability is weaker than that of synthetic products).
(発明が解決しようとする課題)
本発明者は、上述した状況に臨み、ACEの阻害剤を天
然品である食品の中に求約て検討した結果、水抽出物で
はざくろ、スモモ、レモン、カヤノミ、匣鉢、カリンの
中に、界面活性剤抽出物では、トマト、なめこ、ンナモ
ン、グレープフルーツ、ざくろ、キウィフルーツ、スモ
モ、ソルダム、レモン、くちなしの実、カヤノミ、パイ
ナツプル、プラウエア、ネオマスカット、巨峰、かぼす
、柚、カリンなどの中に、ACEを強く阻害する成分が
存在することを見いだし、本発明を完成した。(Problems to be Solved by the Invention) The present inventor faced the above-mentioned situation and investigated the possibility of using ACE inhibitors in natural food products. Surfactant extracts include tomato, nameko, nnamon, grapefruit, pomegranate, kiwifruit, plum, soldum, lemon, garden fruit, kayanomi, pineapple, prawea, neomuscat, and kyoho. The present invention was completed based on the discovery that there is a component that strongly inhibits ACE in fruits such as kabosu, yuzu, and quince.
従って本発明は、本態性高血圧症及び二次性高血圧症で
ある腎性高血圧症或いは内分泌性高血圧症などに惹起す
るACHの活性を阻害する事により、血圧降下への利用
可能な酵素阻害剤を提供することを目的とする。Therefore, the present invention provides an enzyme inhibitor that can be used to lower blood pressure by inhibiting the activity of ACH induced in essential hypertension and secondary hypertension such as renal hypertension or endocrine hypertension. The purpose is to provide.
く課題を解決するための手段)
食品は、日ヌ的に経口摂取されておりその安全性は明ら
かである。食品のACE阻害に関して、大豆やとうもろ
こしなどのプロテアーゼ分解ペプチドの報告がなされて
いる(日本農芸化学会1990年度大会講演要旨集、ρ
247)。また絵本らは食品の水溶性成分のA口上阻害
について報告している (絵本建夫ら:層化、57.1
143 (19g3))。しかし未消化の食品の難水溶
性成分を含tだへ〇ε阻害検索はなされていない。そこ
で本発明者らは、ACEを阻害することにより血圧降下
作用を示す物質を、水抽出物からだけでなく界面活性剤
抽出物から検索すべく研究を重ね、ある種の食品抽出物
に阻害能があることを見いだし、本発明を完成した。Foods are commonly ingested orally in Japan, and their safety is clear. Regarding ACE inhibition in foods, there have been reports on protease-degrading peptides from soybeans, corn, etc. (Japan Society of Agricultural Chemistry 1990 Conference Abstracts, ρ
247). In addition, Ehon et al. have reported on A-oral inhibition of water-soluble components of foods (Takeo Ehon et al.: Stratification, 57.1
143 (19g3)). However, no search for inhibition of 〇ε in undigested foods containing poorly water-soluble components has been made. Therefore, the present inventors have conducted extensive research to search for substances that exhibit a blood pressure lowering effect by inhibiting ACE, not only from water extracts but also from surfactant extracts, and have found that certain food extracts have the ability to inhibit ACE. They discovered that there is, and completed the present invention.
本発明は、食品成分のACE阻害剤を提供する。The present invention provides ACE inhibitors of food ingredients.
本発明に用いる食品は、水溶性阻害成分含有食品ではざ
くろ、スモモ、レモン、カヤノミ、巨I!li、カリン
、難水溶性阻害成分含有食品ではトマト、なめこ、シナ
モン、グレープフルーツ、ざくろ、キウィフルーツ、ス
モモ、ソルダム、レモン、くちなしの実、カヤノミ、パ
イナツプル、テ゛ラウェア、ネオマスカット、巨峰、か
ぼす、柚、カリンなどから1種または2種以上の混合物
を出発原料として用い得る。Foods used in the present invention include pomegranates, plums, lemons, oyster mushrooms, and giant I! foods containing water-soluble inhibitory ingredients. Foods containing li, quince, and poorly water-soluble inhibitory ingredients include tomatoes, nameko mushrooms, cinnamon, grapefruit, pomegranates, kiwifruit, plums, soldum, lemons, garden nuts, pineapple, pineapple, telaware, neomuscat, kyoho, kabosu, yuzu, One type or a mixture of two or more types of quince can be used as a starting material.
本発明に於いて食品からの活性成分の抽出には請求項2
に記載の食品は水、請求項4に記載の食品は界面活性剤
溶液、有機溶剤を用いる。In the present invention, the extraction of active ingredients from foods is claimed in claim 2.
The food according to claim 4 uses water, and the food according to claim 4 uses a surfactant solution and an organic solvent.
請求項2に記載の食品を1種または2種以上出発原料と
して抽出を行うには、食品そのまままたは粉砕あるいは
乾煙した物を常法により抽出を行う。抽出条件は特に制
限されないが、O℃〜100℃の範囲で10分〜24時
間程度行う事が好ましい。In order to perform extraction using one or more of the foods described in claim 2 as starting materials, the extraction is carried out using the food as it is or after it has been crushed or dried and smoked by a conventional method. Extraction conditions are not particularly limited, but it is preferable to carry out the extraction at a temperature in the range of 0°C to 100°C for about 10 minutes to 24 hours.
抽出に際しての水の使用量は、出発原料に対して1倍〜
50倍(重量)程度がよく2〜5倍程度が好ましい。The amount of water used during extraction is ~1 times that of the starting material.
It is preferably about 50 times (by weight), and preferably about 2 to 5 times.
ついで、得られた抽出液を固液分離して固形分を除去し
たのち、必要に応じて濃縮し抽出物質とする。Next, the obtained extract is subjected to solid-liquid separation to remove solid content, and then, if necessary, concentrated to obtain an extracted substance.
請求項4に記載の食品成分抽出に用いられる界面活性剤
は、広範囲な種類の物を含有し、下記の物を例示し得る
。The surfactant used for food component extraction according to claim 4 includes a wide variety of substances, and the following may be exemplified.
アニオン活性剤
タウロコール酸ナトリウム塩等
カチオン活性剤
アミン塩類
第4級アンモニウム塩類等
両性活性剤
ホスファチジルエタノールアミン等
非イオン活性剤
Tween系界面活性剤
Triton系界面活性剤等
また請求項4に記載の食品成分抽出に用いられるを機溶
媒は、広範囲な種類の物を含有し、下記の物を例示し得
る。Anionic surfactants such as taurocholic acid sodium salts, cationic surfactants, amine salts, quaternary ammonium salts, etc. The organic solvent used for extraction includes a wide variety of substances, and examples thereof include those listed below.
アルコール類(無水または含水)
エタノール、メタノール、プロパツール等エステル類
酢酸メチル、酢酸エチル等
エーテル類
ジエチルエーテル、ジプロピルエーテル等ケトン類
アセトン、ジエチルケトン等
炭化水素類
テトラヒドロフラン、ベンゼン等
塩化炭化水素類
クロロホルム等
これらの界面活性剤、有機溶剤は、1種もしくは2種以
上の混合物として用い得る。上記の溶媒を用いて1種ま
た2種以上の食品を出発原料として抽出を行うには、食
品そのまままたは粉砕あるいは乾燥した物を常法により
抽出を行う。抽出条件は特に制限されないが、0℃〜1
00℃の範囲で10分〜24時間程度行うことが好まし
い。Alcohols (anhydrous or water-containing) Ethanol, methanol, propatool, etc. Esters Methyl acetate, ethyl acetate, etc. Ethers Diethyl ether, dipropyl ether, etc. Ketones Acetone, diethyl ketone, etc. Hydrocarbons Tetrahydrofuran, benzene, etc. Chlorinated hydrocarbons Chloroform These surfactants and organic solvents may be used alone or as a mixture of two or more. In order to extract one or more kinds of foods using the above-mentioned solvents as starting materials, extraction is performed on the foods as they are or on crushed or dried foods by a conventional method. Extraction conditions are not particularly limited, but 0°C to 1
It is preferable to carry out the treatment at a temperature of 00°C for about 10 minutes to 24 hours.
抽出に際しての界面活性剤、有機溶剤などの使用量は、
出発原料に対して1倍〜50倍(重@)程度がよく2〜
5倍程度が好ましい。The amount of surfactant, organic solvent, etc. used during extraction is as follows:
It is best to use 1 to 50 times (by weight) of the starting material.
About 5 times is preferable.
ついで、得られた抽出液を固液分離して固形分を除去し
たのち、必要に応じて濃縮し抽出物質とする。Next, the obtained extract is subjected to solid-liquid separation to remove solid content, and then, if necessary, concentrated to obtain an extracted substance.
(酵素活性測定法)
ACE阻害能測定は、被験試料溶液とACE溶液に、基
質(旧ρ−旧5−Leu)を加え、37t 1時間振と
うし、生じたジペプチド(tlis−Leu)を叶フタ
ルジアルデヒドで賦蛍光したのち、蛍光強度を測定(E
X、 340%m Em、 455%m) L、ACE
酵素活性を算出した。具体的には、被験試料溶液(水溶
液及びTCA溶液)50μβにAC”ε溶液(106m
tl/ 5 ng) 20μi、5mM基質溶液(pH
8,3) 240μ矛を加え、以下常法により反応させ
た。被験試料溶液での蛍光強度をS、試料の代わりに水
及びTCA溶液を加えたときの蛍光強度をA、酵素の代
わりに水を加えたときの蛍光強度をBとし、
(S−B) /AX 100 (%)により、AC[
E酵素活性を算出した。酵素がまったく阻害を受けない
とき100%、完全に阻害されたとき0%となる。(Enzyme activity measurement method) To measure ACE inhibitory ability, a substrate (formerly ρ-formerly 5-Leu) was added to the test sample solution and ACE solution, and the resulting dipeptide (tlis-Leu) was shaken at 37t for 1 hour. After fluorescing with phthaldialdehyde, the fluorescence intensity was measured (E
X, 340%m Em, 455%m) L, ACE
Enzyme activity was calculated. Specifically, AC”ε solution (106 m
tl/5 ng) 20μi, 5mM substrate solution (pH
8,3) A 240 µm acetate was added and the reaction was carried out in the following conventional manner. Let S be the fluorescence intensity in the test sample solution, A be the fluorescence intensity when water and TCA solution are added instead of the sample, B be the fluorescence intensity when water is added instead of the enzyme, and (S-B) / By AX 100 (%), AC [
E enzyme activity was calculated. It is 100% when the enzyme is not inhibited at all, and 0% when it is completely inhibited.
次にこの発明の実施例を示すことにより、より一層この
発明の効果が明確になる。Next, by showing examples of the present invention, the effects of the present invention will become clearer.
(実施例)
実施例1
食品の水及び界面活性剤抽出物を調製し、食品の水溶性
成分、難水溶性成分のACEに対する阻害能を検討した
。(Examples) Example 1 Water and surfactant extracts of foods were prepared, and the ability of water-soluble components and poorly water-soluble components of foods to inhibit ACE was examined.
まず原料の食品乾燥物5mgを粉砕し、水及び界面活性
剤溶液1mfl!で5℃−晩抽出する。10.000
Xg、5℃、10分間遠心分離した上澄について、AC
E阻害能を測定した。界面活性剤溶液として5mMタウ
ロコール酸溶液(以下、TCAと略す)を使用した。First, crush 5 mg of the raw material dry food, and add 1 mfl of water and surfactant solution! Extract overnight at 5°C. 10.000
For the supernatant centrifuged for 10 minutes at 5°C, AC
E inhibition ability was measured. A 5mM taurocholic acid solution (hereinafter abbreviated as TCA) was used as a surfactant solution.
水及びTC^抽出液のACE阻害試験結果を第1表に示
す。水抽出液で効果がある、すなわち水溶性の阻害物質
を含をする食品は、ざくろ、スモモ、レモン、カヤノミ
、巨峰、カリンであった。The results of the ACE inhibition test for water and TC^ extracts are shown in Table 1. Foods that were effective with aqueous extracts, that is, contained water-soluble inhibitory substances, were pomegranates, plums, lemons, oyster mushrooms, kyoho grapes, and quince.
TC八へ出液で効果がある、すなわち難水溶性阻害物質
を含有する食品はトマト、なめこ、シナモン、グレープ
フルーツ、ざくろ、キウィフルーツ、スモモ、ソルダム
、レモン、くちなしの実、カヤノミ、パイナツプル、プ
ラウエア、ネオマスカット、巨畦、かぼす、柚、および
カリンであった。Foods that are effective on TC8, that is, contain poorly water-soluble inhibitory substances, include tomatoes, nameko mushrooms, cinnamon, grapefruit, pomegranates, kiwifruit, plums, soldum, lemons, garden berries, pine nuts, pineapple, praware, They were Neomuscat, Kyoze, Kabosu, Yuzu, and Karin.
実施例2
食品の内、パイナツプル、カリン、レモン、スモモの果
肉乾燥物10mgに水及び各種有機溶媒(メタノール、
酢酸エチル、アセトン、テトラヒドロフラン、n−ヘキ
サン、ジエチルエーテル、クロロホルム)2m!を加え
、5℃−晩抽出し、0.5μmフィルターを通して濾別
した抽出液1mlを減圧濃縮しTCAlmfに溶解後、
ACE阻害能を測定した。Example 2 Among foods, 10 mg of dried fruit pulp of pineapple, quince, lemon, and plum was mixed with water and various organic solvents (methanol,
Ethyl acetate, acetone, tetrahydrofuran, n-hexane, diethyl ether, chloroform) 2m! was added, extracted overnight at 5°C, and filtered through a 0.5 μm filter. 1 ml of the extract was concentrated under reduced pressure and dissolved in TCAlmf.
ACE inhibition ability was measured.
結果を第2表に示す。対照として用いた水抽出物だけで
なく有機溶媒抽出物に於いても阻害を示した。7種の有
機溶媒の内、メタノール、酢酸エチル、アセトン、テト
ラヒドロフラン、ジエチルエーテル、クロロホルム抽出
物で効果がみられた。The results are shown in Table 2. Inhibition was shown not only in the aqueous extract used as a control but also in the organic solvent extract. Among the seven organic solvents, methanol, ethyl acetate, acetone, tetrahydrofuran, diethyl ether, and chloroform extracts were effective.
よ 二 ″臣″ 冗に柔ゞ−== 00=W =;0
≧ 爬
輔 q 餡 呂=厄居== 二::3−0に一=2〜0
0く
(発明の効果)
このように本発明によるACε阻害剤は、強い阻害効果
を示し、しかも天然物である食品より抽、出されること
より、安全で有効性の高い血圧降下剤の提供が可能とな
る。Yo 2 ``vassal'' is too flexible -== 00=W =;0
≧ Retsusuke q An Lu = evil house == 2:: 3-0 to 1 = 2 to 0
(Effects of the Invention) As described above, the ACε inhibitor according to the present invention exhibits a strong inhibitory effect, and since it is extracted from food, which is a natural product, it is possible to provide a safe and highly effective antihypertensive agent. It becomes possible.
以上that's all
Claims (1)
含有するアンジオテンシン変換酵素阻害剤。 2、食品としては、ざくろ、スモモ、レモン、カヤノミ
、巨峰、およびカリンから選択抽出された成分を1種も
しくは2種以上を含む混合物である請求項1に記載の酵
素阻害剤。 3、食品を界面活性剤溶液または有機溶媒で抽出して得
られる画分を活性成分として含有するアンジオテンシン
変換酵素阻害剤。 4、食品としては、トマト、なめこ、シナモン、グレー
プフルーツ、ざくろ、キウィフルーツ、スモモ、ソルダ
ム、レモン、くちなしの実、カヤノミ、パイナップル、
デラウェア、ネオマスカット、巨峰、かぼす、柚、およ
びカリンから選択抽出された成分を1種もしくは2種以
上含む混合物である請求項3に記載の酵素阻害剤。 5、有機溶媒は、アルコール類、エステル類、エーテル
類、およびケトン類からなる群から選択された1種もし
くは2種以上の混合物である請求項3に記載の酵素阻害
剤。 6、界面活性剤は、アニオン活性剤、カチオン活性剤、
両性活性剤、および非イオン活性剤から選択される請求
項3に記載の酵素阻害剤。[Scope of Claims] 1. An angiotensin converting enzyme inhibitor containing a fraction obtained by extracting food with water as an active ingredient. 2. The enzyme inhibitor according to claim 1, wherein the food is a mixture containing one or more components selectively extracted from pomegranate, plum, lemon, kayanomi, kyoho, and quince. 3. An angiotensin converting enzyme inhibitor containing a fraction obtained by extracting food with a surfactant solution or an organic solvent as an active ingredient. 4. Foods include tomatoes, nameko mushrooms, cinnamon, grapefruit, pomegranates, kiwifruit, plums, soldum, lemons, garden nuts, pine nuts, pineapples,
The enzyme inhibitor according to claim 3, which is a mixture containing one or more components selectively extracted from Delaware, neomuscat, Kyoho, kabosu, yuzu, and quince. 5. The enzyme inhibitor according to claim 3, wherein the organic solvent is one or a mixture of two or more selected from the group consisting of alcohols, esters, ethers, and ketones. 6. Surfactants include anionic surfactants, cationic surfactants,
Enzyme inhibitor according to claim 3, selected from amphoteric active agents and nonionic active agents.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2245371A JP3009441B2 (en) | 1990-09-13 | 1990-09-13 | Angiotensin converting enzyme inhibitor |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2245371A JP3009441B2 (en) | 1990-09-13 | 1990-09-13 | Angiotensin converting enzyme inhibitor |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH04124140A true JPH04124140A (en) | 1992-04-24 |
JP3009441B2 JP3009441B2 (en) | 2000-02-14 |
Family
ID=17132673
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2245371A Expired - Lifetime JP3009441B2 (en) | 1990-09-13 | 1990-09-13 | Angiotensin converting enzyme inhibitor |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP3009441B2 (en) |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6361807B1 (en) * | 1999-04-19 | 2002-03-26 | Stewart And Lynda Resnick Revocable Trust | Pomegranate extracts and methods of using thereof |
US6641850B1 (en) * | 1999-04-19 | 2003-11-04 | Stewart And Lynda Resnick Revocable Trust | Methods of using pomegranate extracts for causing regression in lesions due to arteriosclerosis in humans |
US7727563B2 (en) | 1999-04-19 | 2010-06-01 | Pom Wonderful, Llc | Methods of using pomegranate extracts for treating diabetes related atherosclerotic complications in humans |
JP2012097008A (en) * | 2010-10-29 | 2012-05-24 | Maruzen Pharmaceut Co Ltd | Sugar-free pineapple extract, method for producing the same, and application of the same |
CN102578571A (en) * | 2012-02-20 | 2012-07-18 | 浙江省林业科学研究院 | Production method of Chinese torreya soft capsules |
US8263140B1 (en) | 2008-04-16 | 2012-09-11 | Pom Wonderful, Llc | Pomegranate based skin protectant and topical application |
US8372454B2 (en) | 1999-04-19 | 2013-02-12 | Pom Wonderful Llc | Methods of making pomegranate compounds for the treatment of erectile dysfunction |
JP2019048903A (en) * | 2011-05-10 | 2019-03-28 | 丸善製薬株式会社 | Tie2 activator, vascular maturing agent, vascular stabilizing agent, and oral composition |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2561086T3 (en) | 2010-12-07 | 2016-02-24 | University Of Oslo | Cardioprotective agents from kiwi |
CA2865092A1 (en) * | 2012-02-21 | 2013-08-29 | University Of Oslo | Cardio-protective agents from kiwifruits |
-
1990
- 1990-09-13 JP JP2245371A patent/JP3009441B2/en not_active Expired - Lifetime
Cited By (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6361807B1 (en) * | 1999-04-19 | 2002-03-26 | Stewart And Lynda Resnick Revocable Trust | Pomegranate extracts and methods of using thereof |
US6641850B1 (en) * | 1999-04-19 | 2003-11-04 | Stewart And Lynda Resnick Revocable Trust | Methods of using pomegranate extracts for causing regression in lesions due to arteriosclerosis in humans |
US6977089B1 (en) * | 1999-04-19 | 2005-12-20 | Stewart And Lynda Resnick Revocable Trust | Methods of using pomegranate extracts for causing regression in lesions due to arteriosclerosis in humans |
US7645469B2 (en) * | 1999-04-19 | 2010-01-12 | Steward And Lynda Resnick Revocable Trust | Methods for treating hypertension in a subject using pomegranate extracts |
US7727563B2 (en) | 1999-04-19 | 2010-06-01 | Pom Wonderful, Llc | Methods of using pomegranate extracts for treating diabetes related atherosclerotic complications in humans |
US7780998B2 (en) | 1999-04-19 | 2010-08-24 | Stewart And Lynda Resnick Revocable Trust | Process for producing a therapeutically effective amount of an extract from pomegranate and compositions relating to same |
US8734868B1 (en) | 1999-04-19 | 2014-05-27 | Pom Wonderful, Llc | Methods of using pomegranate extracts for treating diabetes related atherosclerotic complications in humans |
US8221806B2 (en) | 1999-04-19 | 2012-07-17 | Stewart And Lynda Resnick Revocable Trust | Methods of using pomegranate extracts for causing regression in lesions due to arteriosclerosis in humans |
US8372454B2 (en) | 1999-04-19 | 2013-02-12 | Pom Wonderful Llc | Methods of making pomegranate compounds for the treatment of erectile dysfunction |
US8263140B1 (en) | 2008-04-16 | 2012-09-11 | Pom Wonderful, Llc | Pomegranate based skin protectant and topical application |
JP2012097008A (en) * | 2010-10-29 | 2012-05-24 | Maruzen Pharmaceut Co Ltd | Sugar-free pineapple extract, method for producing the same, and application of the same |
JP2019048903A (en) * | 2011-05-10 | 2019-03-28 | 丸善製薬株式会社 | Tie2 activator, vascular maturing agent, vascular stabilizing agent, and oral composition |
CN102578571A (en) * | 2012-02-20 | 2012-07-18 | 浙江省林业科学研究院 | Production method of Chinese torreya soft capsules |
Also Published As
Publication number | Publication date |
---|---|
JP3009441B2 (en) | 2000-02-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU727283B2 (en) | Process for extraction of proanthocyanidins from botanical material | |
JPH04124140A (en) | Angiotensin-transforming enzyme inhibitor | |
JPH02243632A (en) | Peroxide lipid formation inhibitor comprising vegetable oil extract | |
EP0202275B1 (en) | Skin regenerating cosmetic composition | |
JPH11171758A (en) | Elastase inhibitor and preparation for external use for skin | |
JP3157516B2 (en) | Angiotensin converting enzyme inhibitor | |
US5989429A (en) | Processes for forming stabilized liquid biochemical agricultural products | |
JPH07100016B2 (en) | Food additives | |
JP2009084169A (en) | Xanthone derivative exhibiting collagen-producing activity and method for producing the same | |
JPH0332524B2 (en) | ||
KR101879625B1 (en) | Cosmetic Composition for Improving Atopic Dermatitis Comprising Extract of Tagetes Minuta | |
JP2002284632A (en) | Extinction substance for superoxide anion extracted from sake lees as effective component | |
JP2022008886A (en) | 5α-REDUCTASE INHIBITOR, AND COMPOSITION FOR PREVENTIVE TREATMENT OF ALOPECIA OR HAIR GROWTH PROMOTION, AND METHOD FOR INHIBITING 5α-REDUCTASE IN SCALP AND HAIR GROWTH PROMOTION METHOD | |
KR101076219B1 (en) | Composition for suppressing production of biogenic amines | |
JP2005008541A (en) | Collagenase inhibitor and food containing the same | |
KR101938348B1 (en) | Method for separating fattic acid oil and water-soluble peptide from grub | |
FR2608923A1 (en) | Improvements to processes for obtaining liquid extracts of fresh plants | |
JP2004002267A (en) | Collagenase inhibitor and its utilization | |
JPH03263481A (en) | Eliminating agent of active oxygen | |
KR102728256B1 (en) | Extraction method of natural products using hot water extraction using distilled extract as an extraction solvent | |
JP4190216B2 (en) | UV-induced mutation inhibitor and skin external preparation for UV-induced mutation suppression | |
WO1994020541A1 (en) | Collagenase activity inhibitor and cosmetic composition containing same | |
JPH0995453A (en) | Antimicrobial composition | |
JPH1036257A (en) | Maillard reaction inhibitor | |
SU724116A1 (en) | Method of extracting bitter substances from vegetable raws |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20081203 Year of fee payment: 9 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20101203 Year of fee payment: 11 |
|
EXPY | Cancellation because of completion of term | ||
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20101203 Year of fee payment: 11 |